Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20241211064021N3Phase 3Completed
Phase 3, randomised trial of platelet-rich plasma and medical ozonated water in bursitis (3 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Pain reduction. Started Apr 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20241211064021N3.